Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Food Robotics Market Growth & Trends
The global food robotics market size is expected to reach USD 6.81 billion by 2030, registering a CAGR of 20.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing demand for packaged food, need for automation, increasing food safety regulations, and high labor costs are expected to drive the market.
The industry has witnessed increasing investments in R&D activities, since the past few years, for the development of technologically-advanced robotics and automated systems. The increasing labor costs are driving the packaged food producers toward the adoption of automation systems. The application segments of the market include palletizing, packaging, repackaging, picking, and processing.
The packaging segment is presumed to hold the highest growth rate over the forecast years. The market is witnessing increasing use of packaging automation solutions in food industries. The advantages bestowed by the technology include higher efficiency in food production and processing, increased production efficiency, and consistent quality of products.
The key market participants IN the food robotics market are ABB Group,Kawasaki Heavy Industries Ltd., Fanuc Corporation, Yaskawa Electric Corporation, and others. The vendors in the robotics and automation market are likely to witness increased demand for robotics solutions over the forecast years, owing to the increasing technological advancements.
Food Robotics Market Report Highlights
Food Robotics Market Growth & Trends
The global food robotics market size is expected to reach USD 6.81 billion by 2030, registering a CAGR of 20.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing demand for packaged food, need for automation, increasing food safety regulations, and high labor costs are expected to drive the market.
The industry has witnessed increasing investments in R&D activities, since the past few years, for the development of technologically-advanced robotics and automated systems. The increasing labor costs are driving the packaged food producers toward the adoption of automation systems. The application segments of the market include palletizing, packaging, repackaging, picking, and processing.
The packaging segment is presumed to hold the highest growth rate over the forecast years. The market is witnessing increasing use of packaging automation solutions in food industries. The advantages bestowed by the technology include higher efficiency in food production and processing, increased production efficiency, and consistent quality of products.
The key market participants IN the food robotics market are ABB Group,Kawasaki Heavy Industries Ltd., Fanuc Corporation, Yaskawa Electric Corporation, and others. The vendors in the robotics and automation market are likely to witness increased demand for robotics solutions over the forecast years, owing to the increasing technological advancements.
Food Robotics Market Report Highlights
- Articulated robots dominated the market and accounted for a market revenue share of 41.9% in 2023. The growth is attributed to the articulated robot's structure and design, which mimics a human arm's movements.
- The medium payload segment accounted for the largest revenue share in 2023. Medium payload capability robots address applications such as selecting, repackaging, packing, and transferring.
- The palletizing segment dominated the global industry in 2023. Robots are commonly used for packaging or stacking the food onto pallets for warehousing or transportation.
- Europe's food robotics market dominated the global industry and accounted for a revenue share of 30.6% in 2023. It is attributed to the regulations concerning food safety, the rising labor costs in the region, and the growing inclination towards the automation of multiple processes in the food industry.
- The Asia Pacific food robotics market is anticipated to witness the fastest growth during the forecast period. The rising disposable income of customers in emerging economies is driving the demand for packaged and processed food, which in turn is fueling the need for automation technologies to improve food production capacities.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. FOOT & MOUTH DISEASE VACCINE MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. FOOT & MOUTH DISEASE VACCINE MARKET: ANIMAL ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2023 & 2030 (USD Million)
4.3. Cattle
4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Sheep and Goat
4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Swine
4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. FOOT & MOUTH DISEASE VACCINE MARKET: VACCINE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2023 & 2030 (USD Million)
5.3. Modified/ Attenuated Live
5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inactivated (Killed)
5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. FOOT & MOUTH DISEASE VACCINE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Veterinary Hospitals & Clinics
6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Government Institutions
6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. FOOT & MOUTH DISEASE VACCINE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2023 & 2030 (USD Million)
7.2. Europe
7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. Russia
7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. France
7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Asia Pacific
7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. Japan
7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. China
7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. India
7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. South Korea
7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Indonesia
7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. South Korea
7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Thailand
7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Latin America
7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Brazil
7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Argentina
7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Middle East and Africa
7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. South Africa
7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Saudi Arabia
7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. UAE
7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Kuwait
7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Egypt
7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Turkey
7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Merck & Co., Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Biogenesis Bago
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Zoetis Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Boehringer Ingelheim International GmbH
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Indian Immunologicals Limited
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Bayer AG
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Hester Biosciences Limited
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Brilliant Bio Pharma Limited
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Biovet Private Ltd
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. FOOT & MOUTH DISEASE VACCINE MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. FOOT & MOUTH DISEASE VACCINE MARKET: ANIMAL ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2023 & 2030 (USD Million)
4.3. Cattle
4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Sheep and Goat
4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Swine
4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. FOOT & MOUTH DISEASE VACCINE MARKET: VACCINE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2023 & 2030 (USD Million)
5.3. Modified/ Attenuated Live
5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inactivated (Killed)
5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. FOOT & MOUTH DISEASE VACCINE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Veterinary Hospitals & Clinics
6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Government Institutions
6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. FOOT & MOUTH DISEASE VACCINE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2023 & 2030 (USD Million)
7.2. Europe
7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. Russia
7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. France
7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Asia Pacific
7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. Japan
7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. China
7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. India
7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. South Korea
7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Indonesia
7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. South Korea
7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Thailand
7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Latin America
7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Brazil
7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Argentina
7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Middle East and Africa
7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. South Africa
7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Saudi Arabia
7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. UAE
7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Kuwait
7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Egypt
7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Turkey
7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Merck & Co., Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Biogenesis Bago
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Zoetis Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Boehringer Ingelheim International GmbH
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Indian Immunologicals Limited
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Bayer AG
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Hester Biosciences Limited
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Brilliant Bio Pharma Limited
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Biovet Private Ltd
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
